Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer

This research article has led to a Practice Update in DynaMed Plus. It concludes that addition of pembrolizumab to chemotherapy with pemetrexed and platinum-based drug increases overall survival in patients with previously untreated metastatic nonsquamous non-small cell lung cancer.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news